SCHEMBL19722403

SCHEMBL19722403

C=C(CO)C(=O)OCCOc1ccc(-c2ccc(-c3ccc(C4CCC(CCCCC)CC4)cc3)c(F)c2)c(F)c1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ S1PR1 P21453 2/20 0.39
▸ S1PR3 Q99500 2/20 0.39
▸ RARB P10826 2/20 0.37
▸ RARA P10276 1/20 0.37
▸ FFAR4 Q5NUL3 2/20 0.37
▸ CRBN Q96SW2 1/20 0.36
▸ CYP3A4 P08684 3/20 0.36
▸ CYP2C9 P11712 3/20 0.36
▸ MCL1 Q07820 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ APP P05067 2/20 0.35
▸ PTPN11 Q06124 2/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ CNR2 P34972 1/20 0.34
▸ GPR119 Q8TDV5 1/20 0.34
▸ MOGAT2 Q3SYC2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19722298 0.95 S1PR1 (0.37) S1PR1S1PR3RARBRARAFFAR4
SCHEMBL19721922 0.95 RARB (0.43) S1PR1S1PR3RARBRARAFFAR4
SCHEMBL21322014 0.93 RARB (0.38) S1PR1S1PR3RARBRARAFFAR4
SCHEMBL19721932 0.92 RARB (0.41) S1PR1S1PR3RARBRARAFFAR4
SCHEMBL19722259 0.90 FFAR4 (0.38) S1PR1RARBRARAFFAR4CYP3A4
SCHEMBL19722430 0.89 CYP3A4 (0.35) S1PR1S1PR3RARBRARAFFAR4
SCHEMBL19722468 0.89 RARB (0.42) S1PR1S1PR3RARBRARAFFAR4
SCHEMBL19722371 0.89 FFAR4 (0.38) FFAR4CYP2C9RAB9APTPN11CNR2
SCHEMBL19722321 0.89 RAB9A (0.37) RARBFFAR4CYP2C9RAB9APTPN11
SCHEMBL19722070 0.88 FFAR4 (0.38) RARBFFAR4CYP2C9RAB9APTPN11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210214615-A1 LIQUID CRYSTAL DISPLAY DEVICE AND DISPLAY UNIT JNC CORPORATION (JP) 2021-07-15 — — US disclosed
EP-3257839-B1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORP (JP) 2019-09-04 — — EP disclosed
US-10392339-B2 Polymerizable polar compound, liquid crystal composition, and liquid crystal display element JNC CORPORATION (JP) 2019-08-27 — — US disclosed
WO-2018025974-A1 LIQUID-CRYSTAL DISPLAY ELEMENT AND DISPLAY DEVICE JNC株式会社 2018-02-08 — — WO disclosed
US-20170369418-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT JNC CORPORATION (JP) 2017-12-28 — — US disclosed
EP-3257839-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT JNC Corporation (JP) 2017-12-20 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10392339-B2 Polymerizable polar compound, liquid crystal composition, and liquid crystal display element SP1, HVCN1, CXCR1 S1PR1 106/4885S1PR3 122/4885RARB 2607/4885
US-20170369418-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT SP1, SPIN1, SAV1 S1PR1 122/4885S1PR3 295/4885RARB 1568/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback